Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Payables (2016 - 2026)

Acadia Healthcare Company (ACHC) has disclosed Payables for 17 consecutive years, with $142.2 million as the latest value for Q1 2026.

  • For Q1 2026, Payables fell 30.3% year-over-year to $142.2 million; the TTM value through Mar 2026 reached $142.2 million, down 30.3%, while the annual FY2025 figure was $150.4 million, 35.37% down from the prior year.
  • Payables hit $142.2 million in Q1 2026 for Acadia Healthcare Company, down from $150.4 million in the prior quarter.
  • Across five years, Payables topped out at $232.7 million in Q4 2024 and bottomed at $104.2 million in Q1 2022.
  • Average Payables over 5 years is $156.7 million, with a median of $150.4 million recorded in 2025.
  • Year-over-year, Payables skyrocketed 49.09% in 2023 and then tumbled 35.37% in 2025.
  • Acadia Healthcare Company's Payables stood at $104.7 million in 2022, then soared by 49.09% to $156.1 million in 2023, then skyrocketed by 49.04% to $232.7 million in 2024, then crashed by 35.37% to $150.4 million in 2025, then dropped by 5.45% to $142.2 million in 2026.
  • According to Business Quant data, Payables over the past three periods came in at $142.2 million, $150.4 million, and $179.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.